The safety of sacubitril-valsartan for the treatment of chronic heart failure
JM Tyler, JR Teerlink - Expert Opinion on Drug Safety, 2017 - Taylor & Francis
… of sacubitril-valsartan compared to valsartan on cognitive … in patients with chronic heart
failure with preserved ejection … , a trial of sacubitril–valsartan versus valsartan in patients with …
failure with preserved ejection … , a trial of sacubitril–valsartan versus valsartan in patients with …
Cognitive performance of patients with chronic heart failure on sacubitril/valsartan
R De Vecchis, C Ariano, G Di Biase, M Noutsias - Herz, 2019 - search.proquest.com
… associated with the use of sacubitril/valsartan. In particular, potentially unfavorable effects
of … for heart failure, we aimed at exploring the impact of sacubitril/valsartan administration on …
of … for heart failure, we aimed at exploring the impact of sacubitril/valsartan administration on …
Effect of treatment with sacubitril/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial
DL Mann, MM Givertz, JM Vader, RC Starling… - JAMA …, 2022 - jamanetwork.com
… and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic
heart failure … with the special contribution of the Heart Failure Association (HFA) of the ESC. …
heart failure … with the special contribution of the Heart Failure Association (HFA) of the ESC. …
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
AP Maggioni, I Anand, SO Gottlieb, R Latini… - Journal of the American …, 2002 - jacc.org
… analysis of the Valsartan Heart Failure Trial (Val-HeFT) was performed to evaluate the effects
of the angiotensin II receptor blocker, valsartan, in the patients with chronic heart failure (HF…
of the angiotensin II receptor blocker, valsartan, in the patients with chronic heart failure (HF…
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data
M Wong, L Staszewsky, R Latini, S Barlera… - Journal of the American …, 2004 - jacc.org
… The objective of this study was to test the hypothesis that the severity of left ventricular
remodeling predicts the response to treatment and outcomes in chronic heart failure. …
remodeling predicts the response to treatment and outcomes in chronic heart failure. …
… of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic …
JN Cohn, G Tognoni, RD Glazer, D Spormann… - … of cardiac failure, 1999 - Elsevier
… heart failure, the Valsartan Heart Failure Trial has been designed to investigate the effect of
the angiotensin-receptor blocker, valsartan… York Heart Association classes II to IV heart failure…
the angiotensin-receptor blocker, valsartan… York Heart Association classes II to IV heart failure…
Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐SAS study
D Jaffuel, E Nogue, P Berdague, M Galinier… - … Heart Failure, 2021 - Wiley Online Library
Aims Optimizing medical cardiac treatment for sleep apnoea (SA) in patients with chronic
heart failure and reduced ejection fraction (HFrEF) is an expert Grade C recommendation …
heart failure and reduced ejection fraction (HFrEF) is an expert Grade C recommendation …
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
… risks in patients with chronic heart failure. Our study, in … valsartan and no increased risk
associated with triple therapy in patients with myocardial infarction complicated by heart failure…
associated with triple therapy in patients with myocardial infarction complicated by heart failure…
Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction
ER Cosentino, D Degli Esposti, R Miceli… - Current Medical …, 2019 - Taylor & Francis
… chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart
failure of … Developed with the special contribution of the Heart Failure Association (HFA) of …
failure of … Developed with the special contribution of the Heart Failure Association (HFA) of …
Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival: results from the valsartan heart failure trial
VG Florea, TS Rector, IS Anand… - … : Heart Failure, 2016 - Am Heart Assoc
… In this post hoc analysis of the Valsartan Heart Failure Trial (Val-HeFT) 5 database, we
characterized the subjects who had improved their EF during the first 12 months of follow-up, …
characterized the subjects who had improved their EF during the first 12 months of follow-up, …